Cardiogen is the "heart" name on most bioregulator lists. It sounds like a heart medicine, but the evidence behind it is much smaller than the name suggests. Here's the simple version. WHAT IT IS Cardiogen is a short lab-made peptide of four amino acids: alanine, glutamic acid, aspartic acid, and arginine (written Ala-Glu-Asp-Arg, or AEDR). It comes from the Khavinson bioregulator program in St. Petersburg, Russia, the same research group behind Epitalon, Pinealon, and Cortagen. The idea in that program is that tiny tissue-specific peptides can nudge gene activity in the organ they are named after. For Cardiogen, that organ is the heart. WHAT PEOPLE USE IT FOR • Heart and blood-vessel support ideas in the longevity community • "Aging heart" conversations, especially alongside other bioregulators • Stacking talk with other Khavinson peptides WHAT THE RESEARCH ACTUALLY SHOWS • Tissue culture: the clearest study (Chalisova et al., 2009) took small pieces of heart tissue from young and old rats and grew them in a dish. Cardiogen increased cell growth in both and lowered p53, a protein tied to cell self-destruction. The authors read that as less cell death. • Other lab work: a few more papers, including one on heart fibroblasts (the cells that make scar tissue), come from the same research group. • Humans: there is no published, controlled human trial of Cardiogen, and nothing is registered on ClinicalTrials.gov. Claims you may see online about heart scans improving in older patients do not trace back to a study you can check. Evidence level: Very Early. A handful of cell and tissue studies from one research lineage, with no independent replication and no human outcome data. COMMON QUESTIONS Is Cardiogen a heart medication? No. It is not approved anywhere in the US for any heart condition, and it has not been tested against real heart disease in people. Is it the same as Epitalon or Cortagen? No. They are close cousins with different last amino acids: Epitalon is AEDG, Cortagen is AEDP, and Cardiogen is AEDR.